Revenue
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Encompass Health Corp (EHC)
Price$121.79Cached quote
Net income
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B | $3.57B | $4.61B | $4.28B | $3.91B | $3.64B | — | — | — | — | — | — | — | — |
| Operating expenses | $4.88B | $4.51B | $4.07B | $1.12B | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | $1.05B | $864.5M | $731.8M | $539.5M | $559.6M | $563.9M | $612.1M | $555.2M | $578.3M | $588.1M | $485.7M | — | — | — | — | — | — | — |
| Operating margin | 17.74% | 16.09% | 15.24% | 12.41% | 13.94% | 15.81% | 13.29% | 12.98% | 14.78% | 16.15% | — | — | — | — | — | — | — | — |
| EBITDA | $1.38B | $1.16B | $1.01B | $783.1M | $779.2M | $766.9M | $830.8M | $754.9M | $762.1M | $760.7M | $625.4M | — | — | — | — | — | — | — |
| EBITDA margin | 23.27% | 21.66% | 20.95% | 18.01% | 19.41% | 21.50% | 18.04% | 17.65% | 19.47% | 20.88% | — | — | — | — | — | — | — | — |
| Net income | $566.2M | $455.7M | $352.0M | $271.0M | $412.2M | $284.2M | $358.7M | $292.3M | $271.1M | $247.6M | $183.1M | $222.0M | $323.6M | $185.0M | $208.7M | $899.0M | $94.8M | $252.4M |
| Net profit margin | 9.54% | 8.48% | 7.33% | 6.23% | 10.27% | 7.97% | 7.79% | 6.83% | 6.93% | 6.80% | — | — | — | — | — | — | — | — |
| Basic EPSper basic share | $5.62 | $4.53 | $3.51 | $2.72 | $4.15 | $2.87 | $3.65 | $2.98 | $2.88 | $2.77 | $2.02 | $2.46 | $2.58 | $1.67 | $1.91 | $9.41 | $0.77 | $2.73 |
| Diluted EPSper diluted share | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 | $2.85 | $3.61 | $2.93 | $2.84 | $2.59 | $1.91 | $2.29 | $2.58 | $1.67 | $1.96 | $8.28 | $0.77 | $2.62 |
Owners
Reported shareholders
10.61%of listed shares
BlackRock, Inc.10.48M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 10.61%10.48M shares |
PRICE T ROWE ASSOCIATES INC /MD/ | 5.12%5.06M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 4.98%4.92M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 4.53%4.48M shares |
WELLINGTON MANAGEMENT GROUP LLP | 3.32%3.28M shares |
STATE STREET CORP | 3.22%3.19M shares |
CITADEL ADVISORS LLC | 2.59%2.56M shares |
ALLIANCEBERNSTEIN L.P. | 2.50%2.47M shares |
FULLER & THALER ASSET MANAGEMENT, INC. | 2.49%2.46M shares |
TWO SIGMA INVESTMENTS, LP | 2.30%2.27M shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.91%1.89M shares |
DIMENSIONAL FUND ADVISORS LP | 1.76%1.74M shares |
GOLDMAN SACHS GROUP INC | 1.57%1.55M shares |
Invesco Ltd. | 1.18%1.16M shares |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.17%1.16M shares |
NORGES BANK | 1.17%1.15M shares |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.17%1.15M shares |
MORGAN STANLEY | 1.16%1.15M shares |
JPMORGAN CHASE & CO | 1.15%1.13M shares |
RAYMOND JAMES FINANCIAL INC | 1.08%1.06M shares |
Percentages use 98.8M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 15, 2026Form 4 | COLTHARP DOUGLAS EEVP & Chief Financial Officer | SellEncompass Health Common Stock | 1 | $107.28 | $107.28 | 69.4K |
| May 15, 2026Form 4 | COLTHARP DOUGLAS EEVP & Chief Financial Officer | SellEncompass Health Common Stock | 27.7K | $106.83 | $2.96M | 69.4K |
| May 11, 2026Form 4 | Tuer Patrick WilliamEVP, Chief Operating Officer | SellEncompass Health Common Stock | 682 | $104.56 | $71.3K | 24.8K |
| Mar 9, 2026Form 4 | Fay EdmundSr. Vice Pres. and Treasurer | SellEncompass Health Common Stock | 11.9K | $107.00 | $1.28M | 89.3K |
| Feb 11, 2026Form 4 | Tarr Mark JPresident & CEO | SellEncompass Health Common Stock | 213 | $113.58 | $24.2K | 377.1K |